Cargando…
Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study
BACKGROUND: Cognitive impairment and visual deterioration are two key clinical symptoms in MS and affect 50 to 80% of patients. Little is known about the influence of cognitive impairment on visual tests recommended for MS such as low contrast sensitivity testing. Our objective was to investigate wh...
Autores principales: | Wieder, Laura, Gäde, Gunnar, Pech, Luisa M, Zimmermann, Hanna, Wernecke, Klaus-Dieter, Dörr, Jan-Markus, Bellmann-Strobl, Judith, Paul, Friedemann, Brandt, Alexander U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226200/ https://www.ncbi.nlm.nih.gov/pubmed/24206900 http://dx.doi.org/10.1186/1471-2377-13-167 |
Ejemplares similares
-
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis
por: Schinzel, Johann, et al.
Publicado: (2014) -
Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)
por: Bäcker-Koduah, Priscilla, et al.
Publicado: (2020) -
Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis
por: Dörr, Jan, et al.
Publicado: (2011) -
Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial
por: Dörr, Jan, et al.
Publicado: (2018) -
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial
por: Rust, Rebekka, et al.
Publicado: (2021)